InvestSMART

Galan Lithium Limited (ASX: GLN) - Announcements

- Current share price for GLN : $0.335

ASX company news and announcements for Galan Lithium Limited (GLN) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Galan Lithium Limited (GLN) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Galan Lithium Limited (GLN), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Galan Lithium Limited (GLN)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$425 Successful Completion of Pre-IPO Capital Raise 30 May 2016 9:38AM $0.007 $0.335 risen by 4,685.71%
$425 Change of Registered Office 9 May 2016 10:04AM $0.006 $0.335 risen by 5,483.33%
$425 Zelda Therapeutics Presentation 2 May 2016 9:30AM $0.006 $0.335 risen by 5,483.33%
$425 Quarterly Activities Report 29 Apr 2016 5:27PM $0.006 $0.335 risen by 5,483.33%
$425 Quarterly Cashflow Report 29 Apr 2016 5:26PM $0.006 $0.335 risen by 5,483.33%
$425 Half Yearly Report and Accounts 15 Mar 2016 8:21AM $0.005 $0.335 risen by 6,600%
$425 Leading Paediatric Oncologist Joins Scientific Advisor Board 2 Mar 2016 8:22AM $0.005 $0.335 risen by 6,600%
$425 Distinguished Clinician Joins Zelda Scientific Advisor Board 9 Feb 2016 8:21AM $0.004 $0.335 risen by 8,275%
$425 Quarterly Cashflow Report 29 Jan 2016 2:38PM $0.004 $0.335 risen by 9,471.43%
$425 Quarterly Activities Report 29 Jan 2016 2:37PM $0.004 $0.335 risen by 9,471.43%
$425 Zelda Therapeutics Presentation 17 Dec 2015 2:24PM $0.005 $0.335 risen by 6,600%
$425 Gleneagle to Acquire Zelda Therapeutics Pty Ltd 9 Dec 2015 9:53AM $0.008 $0.335 risen by 4,087.50%
$425 Trading Halt 7 Dec 2015 9:40AM $0.008 $0.335 risen by 4,087.50%
$425 Results of Meeting 25 Nov 2015 4:10PM $0.010 $0.335 risen by 3,250%
$425 Quarterly Cashflow Report 29 Oct 2015 6:11PM $0.004 $0.335 risen by 8,275%
$425 Quarterly Activities Report 29 Oct 2015 6:10PM $0.004 $0.335 risen by 8,275%
$425 Appendix 3B and Section 708A(5) Notice 23 Oct 2015 6:53PM $0.004 $0.335 risen by 8,275%
$425 Notice of Annual General Meeting/Proxy Form 23 Oct 2015 4:51PM $0.004 $0.335 risen by 8,275%
$425 Capital Raising 13 Oct 2015 8:25AM $0.004 $0.335 risen by 8,275%
$425 Appendix 4G 22 Sep 2015 2:33PM $0.003 $0.335 risen by 11,066.67%
$425 Annual Report 22 Sep 2015 2:33PM $0.003 $0.335 risen by 11,066.67%
$425 Myostin Merger not Proceeding 1 Sep 2015 6:49PM $0.002 $0.335 risen by 16,650%
$425 Quarterly Cashflow Report 31 Jul 2015 12:52PM $0.003 $0.335 risen by 11,066.67%
$425 Quarterly Activities Report 31 Jul 2015 12:52PM $0.003 $0.335 risen by 11,066.67%
$425 Change of Director's Interest Notice x 3 6 Jul 2015 6:31PM $0.003 $0.335 risen by 11,066.67%

826 - 850 of 997 results

Page 34 of 40

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.